Evidence map›Paper›PMID 33410054›Full record

ArticleEnvironmental science and pollution research international2021

Occurrence of caffeine, fluoxetine, bezafibrate and levothyroxine in surface freshwater of São Paulo State (Brazil) and risk assessment for aquatic life protection.

Raquel Cardoso de Souza, Aline Andrade Godoy, Fábio Kummrow, Thyago Leandro Dos Santos, Carlos Jesus Brandão, Ernani Pinto

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Raquel Cardoso de SouzaDepartment of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo (USP), Avenida Professor Lineu Prestes, 580, São Paulo, SP, 05508-000, Brazil.
Aline Andrade GodoyDepartment of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo (USP), Avenida Professor Lineu Prestes, 580, São Paulo, SP, 05508-000, Brazil.
Fábio KummrowInstitute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo (Unifesp), Rua São Nicolau, 210, Diadema, SP, 09972-270, Brazil. fkummrow@unifesp.br.ORCID http://orcid.org/0000-0003-2977-0108
Thyago Leandro Dos SantosDepartment of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo (USP), Avenida Professor Lineu Prestes, 580, São Paulo, SP, 05508-000, Brazil.
Carlos Jesus BrandãoEnvironmental Company of State of São Paulo (CETESB), Av. Professor Frederico Hermann Júnior, 345, Alto de Pinheiros, São Paulo, SP, 05459-900, Brazil.
Ernani PintoDepartment of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo (USP), Avenida Professor Lineu Prestes, 580, São Paulo, SP, 05508-000, Brazil.
Universidade de São Paulo · BRCompanhia Energética de São Paulo · BRUniversidade Federal de São Paulo · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2010/50739-4
6 · The paper itself

Abstract

The prioritization of active pharmaceutical ingredients (APIs) for monitoring programmes and/or environmental risk assessment (ERA) purposes is based on several criteria, including environmental occurrence data. However, data on API occurrence in Brazilian surface freshwaters are still scarce. The Brazilian Unified Health System (SUS) provides several medicines free-of-charge, including medications that have bezafibrate, fluoxetine and levothyroxine as the API. Thus, our objective was to investigate the occurrence of bezafibrate, fluoxetine and levothyroxine in samples collected at sampling sites included in the surface freshwater monitoring program of the São Paulo State Environmental Agency (CETESB); caffeine was also included in the analysis because it is commonly used as an anthropogenic marker of aquatic environment contamination. Monitoring results showed that levothyroxine was not found in any of the analysed samples. Caffeine was ubiquitous in the analysed samples, thus indicating anthropic contamination in the studied water bodies. Caffeine and bezafibrate presented risk quotient (RQ) < 1 for all the sampling sites and periods evaluated in this study. For fluoxetine, RQs > 1 were found in all water samples in which this API was found, indicating a potential risk for freshwater pelagic biota. Thus, fluoxetine should be regulated in São Paulo State in order to protect the aquatic biota. Additional occurrence studies in other Brazilian states are still needed to evaluate if fluoxetine is a nationwide pollutant.

Indexed as

Environmental MonitoringWater Pollutants, ChemicalBezafibrateBrazilCaffeineFluoxetineFresh WaterRisk AssessmentThyroxineBezafibrateCaffeineFluoxetineThyroxineWater Pollutants, ChemicalActive pharmaceutical ingredientsContaminants of emerging interestLiquid chromatography-tandem mass spectrometryPelagic biotaRisk quotient

Identifiers

PMID33410054
OpenAlexW3119714006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.